Skip to content

Clinical trials

Phase 3 Intestinal Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Intestinal Diseases Phase: Phase 3 Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20093
20112
20121
20132
20142
20153
20163
20171
20182
20201
20212
20221
20231
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated5
Active, not recruiting4
Recruiting3
Unknown status3
Withdrawn1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bausch Health Americas, Inc.3
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)3
Menarini Group3
Pharmbio Korea Co., Ltd.3
Pfizer2
Zealand Pharma2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
AstraZeneca1
Azienda Ospedaliera "Sant'Andrea"1
Beijing Bozhiyin T&S Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Intestinal Diseases33
Digestive System Diseases18
Gastrointestinal Diseases18
Colonic Diseases13
Rectal Diseases8
Pathologic Processes7
Colorectal Neoplasms5
Digestive System Neoplasms5
Gastroenteritis5
Gastrointestinal Neoplasms5

Trials

Showing 26 to 33 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.